“We are investigating potential monkeypox vaccines at the preclinical level,” the company said in a Twitter post.
Earlier, the head of Rospotrebnadzor, Anna Popova, said that a test system for smallpox viruses was registered in Russia five to seven years ago.
Corresponding Member of the Russian Academy of Sciences, Professor and Chief Researcher of the Institute of Molecular Biology of the Russian Academy of Sciences Pyotr Chumakov, in an interview with RT, noted that a vaccine created against smallpox can provide protection against the monkeypox virus, and stocks of such drugs still exist in a number of countries.